156 related articles for article (PubMed ID: 18769915)
1. The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype.
Lamberth K; Røder G; Harndahl M; Nielsen M; Lundegaard C; Schafer-Nielsen C; Lund O; Buus S
Immunogenetics; 2008 Nov; 60(11):633-43. PubMed ID: 18769915
[TBL] [Abstract][Full Text] [Related]
2. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.
Sidney J; Southwood S; Sette A
Immunogenetics; 2005 Jul; 57(6):393-408. PubMed ID: 16003466
[TBL] [Abstract][Full Text] [Related]
3. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.
Burrows SR; Elkington RA; Miles JJ; Green KJ; Walker S; Haryana SM; Moss DJ; Dunckley H; Burrows JM; Khanna R
J Immunol; 2003 Aug; 171(3):1407-12. PubMed ID: 12874232
[TBL] [Abstract][Full Text] [Related]
4. Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs.
McKinney DM; Erickson AL; Walker CM; Thimme R; Chisari FV; Sidney J; Sette A
J Immunol; 2000 Oct; 165(8):4414-22. PubMed ID: 11035079
[TBL] [Abstract][Full Text] [Related]
5. Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules.
Zhu S; Udaka K; Sidney J; Sette A; Aoki-Kinoshita KF; Mamitsuka H
Bioinformatics; 2006 Jul; 22(13):1648-55. PubMed ID: 16613909
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the differential classification of HLA-A*6802 and HLA-A*6801 into the A2 and A3 supertypes.
Niu L; Cheng H; Zhang S; Tan S; Zhang Y; Qi J; Liu J; Gao GF
Mol Immunol; 2013 Oct; 55(3-4):381-92. PubMed ID: 23566939
[TBL] [Abstract][Full Text] [Related]
7. Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.
Honeyborne I; Rathod A; Buchli R; Ramduth D; Moodley E; Rathnavalu P; Chetty S; Day C; Brander C; Hildebrand W; Walker BD; Kiepiela P; Goulder PJ
J Immunol; 2006 Apr; 176(8):4699-705. PubMed ID: 16585563
[TBL] [Abstract][Full Text] [Related]
8. Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles.
Matsueda S; Takedatsu H; Yao A; Tanaka M; Noguchi M; Itoh K; Harada M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6933-43. PubMed ID: 16203785
[TBL] [Abstract][Full Text] [Related]
9. Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.
Rasmussen M; Harndahl M; Stryhn A; Boucherma R; Nielsen LL; Lemonnier FA; Nielsen M; Buus S
J Immunol; 2014 Nov; 193(10):4790-802. PubMed ID: 25311805
[TBL] [Abstract][Full Text] [Related]
10. The HLA A03 Supertype and Several
de Groot NG; Heijmans CMC; de Ru AH; Otting N; Koning F; van Veelen PA; Bontrop RE
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075930
[TBL] [Abstract][Full Text] [Related]
11. Identifiying human MHC supertypes using bioinformatic methods.
Doytchinova IA; Guan P; Flower DR
J Immunol; 2004 Apr; 172(7):4314-23. PubMed ID: 15034046
[TBL] [Abstract][Full Text] [Related]
12. Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.
Kessler JH; Mommaas B; Mutis T; Huijbers I; Vissers D; Benckhuijsen WE; Schreuder GM; Offringa R; Goulmy E; Melief CJ; van der Burg SH; Drijfhout JW
Hum Immunol; 2003 Feb; 64(2):245-55. PubMed ID: 12559627
[TBL] [Abstract][Full Text] [Related]
13. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
[TBL] [Abstract][Full Text] [Related]
14. Improving the prediction of HLA class I-binding peptides using a supertype-based method.
Wang S; Bai Z; Han J; Tian Y; Shang X; Wang L; Li J; Wu Y
J Immunol Methods; 2014 Mar; 405():109-20. PubMed ID: 24508661
[TBL] [Abstract][Full Text] [Related]
15. HLA class I supertypes: a revised and updated classification.
Sidney J; Peters B; Frahm N; Brander C; Sette A
BMC Immunol; 2008 Jan; 9():1. PubMed ID: 18211710
[TBL] [Abstract][Full Text] [Related]
16. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration.
Tanaka M; Tanaka K; Tsuji S; Kawata A; Kojima S; Kurokawa T; Kira J; Takiguchi M
J Neurol Sci; 2001 Jul; 188(1-2):61-5. PubMed ID: 11489286
[TBL] [Abstract][Full Text] [Related]
18. Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules.
Sidney J; Asabe S; Peters B; Purton KA; Chung J; Pencille TJ; Purcell R; Walker CM; Chisari FV; Sette A
Immunogenetics; 2006 Jul; 58(7):559-70. PubMed ID: 16791621
[TBL] [Abstract][Full Text] [Related]
19. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.
Horiguchi Y; Nukaya I; Okazawa K; Kawashima I; Fikes J; Sette A; Tachibana M; Takesako K; Murai M
Clin Cancer Res; 2002 Dec; 8(12):3885-92. PubMed ID: 12473604
[TBL] [Abstract][Full Text] [Related]
20. Definition of supertypes for HLA molecules using clustering of specificity matrices.
Lund O; Nielsen M; Kesmir C; Petersen AG; Lundegaard C; Worning P; Sylvester-Hvid C; Lamberth K; Røder G; Justesen S; Buus S; Brunak S
Immunogenetics; 2004 Mar; 55(12):797-810. PubMed ID: 14963618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
